Aghamohammadi Asghar, Mohammadinejad Payam, Abolhassani Hassan, Mirminachi Babak, Movahedi Masoud, Gharagozlou Mohammad, Parvaneh Nima, Zeiaee Vaheid, Mirsaeed-Ghazi Bahram, Chavoushzadeh Zahra, Mahdaviani Alireza, Mansouri Mahboubeh, Yousefzadegan Sedigheh, Sharifi Bahareh, Zandieh Fariborz, Hedayat Ehsan, Nadjafi Ali, Sherkat Roya, Shakerian Behzad, Sadeghi-Shabestari Mahnaz, Hosseini Reza Farid, Jabbari-Azad Farahzad, Ahanchian Hamid, Behmanesh Fatemeh, Zandkarimi Mohammadreza, Shirkani Afshin, Cheraghi Taher, Fayezi Abbas, Mohammadzadeh Iraj, Amin Reza, Aleyasin Soheila, Moghtaderi Mojgan, Ghaffari Javad, Arshi Saba, Javahertrash Naser, Nabavi Mohammad, Bemanian Mohammad Hassan, Shafiei Alireza, Kalantari Najmedin, Ahmadiafshar Akefeh, Khazaei Hossein Ali, Atarod Lida, Rezaei Nima
J Clin Immunol. 2014 May;34(4):478-90. doi: 10.1007/s10875-014-0001-z.
Primary immunodeficiency disorders (PID) are a group of heterogeneous disorders mainly characterized by severe and recurrent infections and increased susceptibility to malignancies, lymphoproliferative and autoimmune conditions. National registries of PID disorders provide epidemiological data and increase the awareness of medical personnel as well as health care providers.
This study presents the demographic data and clinical manifestations of Iranian PID patients who were diagnosed from March 2006 till the March of 2013 and were registered in Iranian PID Registry (IPIDR) after its second report of 2006.
A total number of 731 new PID patients (455 male and 276 female) from 14 medical centers were enrolled in the current study. Predominantly antibody deficiencies were the most common subcategory of PID (32.3 %) and were followed by combined immunodeficiencies (22.3 %), congenital defects of phagocyte number, function, or both (17.4 %), well-defined syndromes with immunodeficiency (17.2 %), autoinflammatory disorders (5.2 %), diseases of immune dysregulation (2.6 %), defects in innate immunity (1.6 %), and complement deficiencies (1.4 %). Severe combined immunodeficiency was the most common disorder (21.1 %). Other prevalent disorders were common variable immunodeficiency (14.9 %), hyper IgE syndrome (7.7 %), and selective IgA deficiency (7.5 %).
Registration of Iranian PID patients increased the awareness of medical community of Iran and developed diagnostic and therapeutic techniques across more parts of the country. Further efforts must be taken by increasing the coverage of IPIDR via electronically registration and gradual referral system in order to provide better estimation of PID in Iran and reduce the number of undiagnosed cases.
原发性免疫缺陷病(PID)是一组异质性疾病,主要特征为严重且反复的感染,以及患恶性肿瘤、淋巴增殖性疾病和自身免疫性疾病的易感性增加。PID疾病的国家登记处提供流行病学数据,并提高医务人员以及医疗服务提供者的认识。
本研究呈现了2006年3月至2013年3月期间被诊断出的伊朗PID患者的人口统计学数据和临床表现,这些患者在2006年第二次报告后被登记在伊朗PID登记处(IPIDR)。
本研究纳入了来自14个医疗中心的731例新PID患者(455例男性和276例女性)。主要的抗体缺陷是PID最常见的亚类(32.3%),其次是联合免疫缺陷(22.3%)、吞噬细胞数量、功能或两者的先天性缺陷(17.4%)、明确的免疫缺陷综合征(17.2%)、自身炎症性疾病(5.2%)、免疫失调疾病(2.6%)、先天免疫缺陷(1.6%)和补体缺陷(1.4%)。严重联合免疫缺陷是最常见的疾病(21.1%)。其他常见疾病为普通可变免疫缺陷(14.9%)、高IgE综合征(7.7%)和选择性IgA缺乏(7.5%)。
伊朗PID患者的登记提高了伊朗医学界的认识,并在该国更多地区发展了诊断和治疗技术。必须通过电子登记和逐步转诊系统扩大IPIDR的覆盖范围,以更好地估计伊朗的PID情况并减少未诊断病例数量。